Arrowhead PharmaceuticalsARWR
那斯達克 · USD
73.09
-2.07
(-2.75%)
收盤 06/06 03:59 (UTC+8)
06/06 03:59 (UTC+8)
Arrowhead PharmaceuticalsARWR
73.09
-2.07
(-2.75%)
財務數據
損益表
- 0.04
- -
- -
- -
- 0.03
- 5.43
- 0.28
- 2.56
- 2.64
- 0.74
- -77.94
- -
- -
- -
- -
- 21608.36
- -94.88
- 823.66
- 2.95
- -72.07
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 73,737 | 264,033 | 256,472 | 27,767 | 542,709 | 2,500 | - | - | - | 3,551 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 73,737 | 264,033 | 256,472 | 27,767 | 542,709 | 2,500 | - | - | - | 3,551 |
營業費用 | 214,997 | 223,224 | 212,366 | 193,317 | 161,507 | 163,912 | 162,203 | 176,141 | 126,191 | 140,096 |
研發費用 | 173,253 | 177,203 | 174,687 | 162,368 | 133,102 | 137,002 | 135,826 | 152,431 | 101,122 | 116,491 |
推銷及管理費用 | 41,744 | 46,021 | 37,679 | 30,949 | 28,405 | 26,910 | 26,377 | 23,710 | 25,069 | 23,605 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -141,260 | 40,809 | 44,106 | -165,550 | 381,202 | -161,412 | -162,203 | -176,141 | -126,191 | -136,545 |
其他收入及費用 | 34,261 | 9,967 | 13,709 | 10,843 | 10,053 | 7,943 | 4,052 | 7,258 | 6,439 | 3,223 |
利息費用 | 23,846 | 22,505 | 21,694 | 24,382 | 21,639 | 21,646 | 14,647 | 5,094 | 7,244 | 5,367 |
稅前純益 | -137,564 | 28,271 | 36,121 | -179,089 | 369,616 | -175,115 | -172,798 | -173,977 | -126,996 | -138,689 |
所得稅 | 6 | 29 | 20,000 | -437 | 1,753 | 103 | 546 | - | - | -3,313 |
稅後純益 | -132,730 | 30,811 | -23,750 | -175,241 | 370,445 | -173,085 | -170,536 | -170,793 | -125,300 | -132,864 |
基本每股稅後盈餘(元) | -0.93 | 0.22 | -0.14 | -1.26 | 2.78 | -1.39 | -1.36 | -1.38 | -1.02 | -1.24 |
稀釋每股稅後盈餘(元) | -0.95 | 0.22 | -0.18 | -1.35 | 2.91 | -1.39 | -1.37 | -1.39 | -1.00 | -1.24 |
基本平均股數(千股) | 142417.00 | 137039.00 | 137782.00 | 139039.00 | 133363.00 | 124848.00 | 124237.00 | 124199.00 | 123285.00 | 107415.00 |
稀釋平均股數(千股) | 142417.00 | 140706.00 | 136661.00 | 139039.00 | 134484.00 | 124848.00 | 124237.00 | 124199.00 | 123285.00 | 107415.00 |
還原基本每股稅後盈餘(元) | -0.93 | 0.22 | -0.14 | -1.26 | 2.78 | -1.39 | -1.36 | -1.38 | -1.02 | -1.24 |
還原稀釋每股稅後盈餘(元) | -0.95 | 0.22 | -0.18 | -1.35 | 2.91 | -1.39 | -1.37 | -1.39 | -1.00 | -1.24 |
還原基本平均股數(千股) | 142,417 | 137,039 | 137,782 | 139,039 | 133,363 | 124,848 | 124,237 | 124,199 | 123,285 | 107,415 |
還原稀釋平均股數(千股) | 142,417 | 140,706 | 136,661 | 139,039 | 134,484 | 124,848 | 124,237 | 124,199 | 123,285 | 107,415 |
EBITDA(千元) | -103,153 | 58,520 | 23,086 | -146,830 | 402,837 | -151,805 | -161,448 | -153,927 | -111,800 | -127,382 |